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The demographics of the U.S. population is shifting 
such that the CDC estimates that by the year 2050 the 
number of people over the age of 65 will double as will 
the prevalence of age related disease [1]. This aging 
population is predicted to increase medical, economic 
and social burdens on society due to increased care 
needs. In the U.S. it is estimated that more than 60% of 
people over the age of 65 suffer from hypertension, 
roughly 40% are obese, 21% are in fair or poor health, 
and 7% need personal daily care [2-5]. Due to the 
shifting demographic needs and potential health impact 
on  the  population,  research  in  geriatrics  has  recently  
 
shifted its focus from centering on human longevity to 
improving human health span and quality of life. Aging 
research is now evaluating systemic aging processes 
rather than concentrating on individual diseases such as 
diabetes, cardiovascular disease, Alzheimer’s, dementia, 
and sarcopenia, in hopes that all of the disease 
progressions will be slowed with bettered health span 
for individuals [6, 7].  
  
Animal models offer many advantages in studies of 
aging and health span research. Work with rodents has 
been extensive due to the fact that they are mammals 
that have a relatively short lifespan [8, 9]. Mice in 
particular have historically been used due to their ease 






























of  aging  research.  The marmosets were  screened  for  two  viruses  and  several  bacterial  pathogens  prior  to
establishing  the  new  SPF  colony.  Twelve  founding  animals  successfully  established  a  breeding  colony with
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of care, rapid developmental and reproductive rate, and 
the ability to create genetic mutant lines. The ease of 
manipulation has allowed extensive evaluation of 
molecular mechanisms of aging, developmental and 
environmental factors associated with aging, and the 
effects of interventional and therapeutic treatments on 
aging and health span in these species. The gold 
standard for extending life span in rodent studies is the 
use of caloric restriction, which has reliably increased 
both lifespan and health span measures in specific 
strains of mice [10-12]. Many new drugs of interest, 
including rapamycin, have been tested in rodents and 
continue to reveal details regarding aging and disease 
progression [13-15]. However, there are many concerns 
regarding the use of rodents as the only mammalian 
models of aging, since many of the drugs tested in 
rodents do not translate successfully to humans.  
Further, inbred strains of mice often have selected traits 
that are negative by-products of breeding [16]. 
Therefore, it is necessary to expand the comparative 
biology of aging approach in conjunction with the use 
of model organisms to evaluate life and health span.  
  
Nonhuman primates offer a unique alternative for 
modeling questions in aging research due to their close 
relation to humans and the increased likelihood of 
translation of discoveries to human diseases. In 
particular, nonhuman primates may be valuable in 
serving as an intermediary for intervention testing, as 
has recently been demonstrated in the evaluation of 
rapamycin [17-19]. However, most nonhuman primate 
biomedical models have longevity longer than a 
researcher’s career and are expensive to maintain and 
test.  
 
The marmoset is a small bodied, short lived primate that 
has recently been developed as an alternative model for 
aging research [20, 21]. Prior to 2012, the average 
lifespan for marmosets was typically reported as 
approximately 5-6 y, with animals considered aged at 8 
y and a maximum age of 16 y [20-22]. However, two 
published reports suggest that these typically reported 
average and maximum lifespans do not reflect the true 
lifespan potential of the species. Ridley, et al. [23] 
reported on a small breeding colony at Cambridge 
University in which 80% of individuals were still alive 
at age 10 y and the maximum lifespan was 19 y. In 
2012, a marmoset colony in Japan (CLEA) reported an 
average lifespan of 12 y with a maximum of 22 y. The 
dynamics in these colonies that led to the extended 
lifespan is unclear, but Nishijima, et al. (2012) propose 
that the extended longevity in their closed colony was 
due to few infection related deaths.  
 
Survival curves reported for marmosets typically exhibit 
a normal primate linear decline in middle age rather 
than the plateaued survival typical of mouse models and 
Western human populations [21]. Such a pattern 
appears typical for conventionally maintained, captive 
nonhuman primate populations [24]. The use of 
marmosets as biomedical models for aging research 
would be greatly enhanced if the marmoset longevity 
curve could be reshaped to resemble the plateaued 
human and mouse model curves. These plateaued 
curves typically represent lower death rates in middle 
age and few deaths due to illness or pathogens. The 
history of mouse longevity has changed dramatically 
with the introduction of barrier colony maintenance. In 
the past mouse longevity resembled current primate 
survivorship with linear decline in middle age.  
Alterations of environmental control and medical 
intervention have resulted in increased survivability and 
plateaued mid-life survivorship [25, 26]. Barrier 
maintenance of animal colonies typically includes 
controlled entry, strict quarantine procedures, 
disinfection protocols for all items into the animal 
space, controlled air flow, pure dietary sources and 
autoclaved water. Rodent barrier colonies implement 
these strategies at varying degrees depending on strain 
and risk of contamination from other sources [9].  
 
Given the need for a short-lived nonhuman primate as a 
model of aging, the reported increased longevity from 
the closed Japanese colony, and the shifts in rodent 
survival under barrier conditions, we developed a 
barrier maintained specific pathogen free (SPF) 
marmoset colony.  We hypothesized that maintaining 
marmosets in barrier conditions would increase 
marmoset longevity, alter the survivorship curves for 
marmosets and improve marmoset health measures. 
This paper describes the development of that colony, 
and compares health and lifespan outcomes of the SPF 
colony with the conventionally housed colony from 




Establishment of SPF marmosets 
 
Marmosets (28 males, 31 females) from Southwest 
National Primate Research Center (SNPRC) were 
screened for pathogens to identify potential founders for 
the SPF colony. The presence of viremia was analyzed 
for GB virus-A (GBV) and Callitrichine Herpes virus-3 
(CHV) in 50 selected individuals. Due to the 
characteristics of the two viruses processing of blood 
samples differed prior to assay.  CHV is a DNA virus 
related to the Epstein Barr Virus, a herpes virus. The 
virus is primarily present in B lymphocytes, so DNA 
was purified from a total blood cell pellet for PCR. 
GBV-A is an RNA virus distantly related to hepatitis C 
virus, a flavivirus, and was detected in serum derived 
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RNA by RT-PCR.  The overall prevalence for males 
and females was approximately the same for both 
viruses. The small sample size did not allow an 
estimation of whether the infection rate changed with 
age. The prevalence for CHV in a group of 50 animals 
ranging from 1-4 years of age was 60% with 20 
negative animals (Table 1A). The same group had a 
prevalence of 36% for GBV-A with 32 negative 
animals. Repeat screening of 12 animals resulted in two 
discordant values for CHV. One detected the conversion 
of the animal to positive over a 19-month period and 
continued confirmation of that positive result on 
subsequent bleeds. Within the group of 50 animals 
screened, 16 animals were double negative and suitable 
for selection for the barrier colony. Animals were also 
screened for the presence of fecal pathogens including 
Giardia, Cryptosporidium and Clostridium perfringens 
and the frequency of positive screens are shown in 
Table 1B. Six females and six males were determined to 




































interest and were moved to the Texas Research Park to 
found the SPF barrier colony. An assessment for viral 
presence 12 months after the founding of the barrier 
colony revealed one male to be positive for CHV and he 
was moved back to SNPRC. No other animals were 
noted to be positive for these viruses of interest at that 
time, or when screened 6 years after founding the 
colony. Animals from the barrier colony were screened 
for fecal pathogens annually in years three, four and 
five after forming the barrier colony; the rates of 
positive screens are in Table 1B. Age and sex matched 
animals from the conventional colony were screened for 
fecal pathogens as well and the rates of positive screens 
are also in Table 1B. The prevalence of 
Cryptosporidium and Clostridium perfringens were 
very low in both the conventional and the barrier 
colony. Giardia was more prevalent than the other fecal 
pathogens, though prevalence of Giardia remained 
significantly lower in the barrier than in the 









































Age Females Males Totals 
 n % n % n % 
1 9/16 56.3 6/10 60 15/26 57.7 
2 4/5 80 6/8 75 10/13 76.9 
3-4 3/6 50 2/5 40 5/11 45.5 
Total 16/27 59.3 14/23 60.9 30/50 60 
       
GBV 
Age Females Males Totals 
 n % n % n % 
1 6/16 37.5 6/10 60 12/26 46.2 
2 1/5 20 1/8 12.5 2/13 15.4 
3-4 2/6 33.3 2/5 40 4/11 36.4 
Total 9/27 33.3 9/23 39.1 18/50 36 




Sex Number Giardia Cryptosporidium 
Clostridium 
perfringens 
Initial Screen Female 15 4 1 2 Male 18 5 1 0 
Barrier  Female 28 2 0 0 
Maintenance Male 19 2 0 0 
Conventional  Female 16 5 0 1 
Comparison Male 12 2 0 4 
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Colony growth 
  
The colony began with a single breeding pair that was 
imported in July 2007, followed by three pairs in July 
2008 and four more individuals between August 2009 
and April 2010. These founding six breeding pairs 
produced 36 litters. Breeding pairs of unrelated 
individuals were formed when the animals were at least 
two years old and between December 2007 and August 
2016 the SPF barrier colony produced 98 litters 
consisting of 275 infants from 27 breeding females and 
23 breeding males. The litters in the colony consisted of 
four aborted pregnancies of unknown litter size, three 
singletons, 20 twin, 53 triplet, 17 quadruplet and one 
quintuplet litter. The reproductive outcomes are 
summarized in Table 2. Overall the reproduction in the 
barrier colony was comparable to that reported for other 
colonies including the conventionally housed SNPRC 
colony (Table 2). On average the barrier colony 
produced two surviving infants per female per year 
while the SNPRC colony produces 1.6-1.8 infants per 
female per year. The use of rotational hand rearing in 
the barrier, which consisted of the rotational removal of 
a single infant from the family group for daily 
supplementation and return to the family each day, led 
to higher survival rates amongst triplet litters than those 
litters in which it wasn’t implemented. For triplet litters 
in which all infants were born alive, rotational rearing 
resulted in 83.3% of infants surviving through the first 
14 days, while not implementing rotational rearing 
resulted in 50.6% of infants surviving. If litters that were 
rotationally reared were removed from the analysis 
97.1% of infants that survived to 14 days in the barrier 
colony survive to six months, 97.1% to 12 months, and 
97.1% to 18 months meaning there was no loss of infants 
between the ages of six months and 18 months in the SPF 
colony. In comparison to infants at SNPRC that were not 


















for experimental deaths, 89.2% survived to six months, 
81% to 12 months, and 68.4% survived to 18 months.  
 
Longevity in barrier 
 
Maintaining marmosets in barrier conditions 
significantly increased the survival of animals, and adult 
survivorship plateaued in both males and females when 
compared to marmosets maintained in conventional 
housing protocols at SNPRC (Figure 1). We compared 
survival in a population of 247 barrier animals (115 
females and 132 males) versus a population of 370 
conventionally housed animals (173 females and 197 
males) over a 10-year period. Barrier females had a 
median lifespan of 8.9 y (95% CI 5.9+ y, upper 
confidence limit could not be determined due to 
censoring) compared to a median lifespan of 4.86 y 
(95% CI 4.06 to 6.38 y) at the primate center with a 
hazard ratio relative to barrier females of 2.8 (p = 
0.001). The female barrier survivorship curve displays a 
predicted precipitous decline at 9 y which we believe 
was due to the fact that the longest lived females died, 
while many middle-aged females were still alive and 
censored.  We remain confident that a difference 
between the colonies exists based on the Cox 
proportional hazard analysis and the differences in the 
median lifespan and their confidence limits. Further, 
barrier males had a median lifespan of 8.64 y (95% CI 
7.6+ y, upper limit could not be determined due to 
censoring) compared to the 5.08 y (95% CI 4.33 to 7.61 
y) at SNPRC with a hazard ratio relative to barrier of 
3.44 (p =0.001). Because the populations were tracked 
for no more than 10 years, there is not a valid lifespan 
comparison of the SPF colony data with that from the 
CLEA colony in Japan (Nishijima et al.,2012). 
However, the early to mid-adulthood survival 
percentages suggest that the barrier and CLEA 





















Colony Pregnancies # of infants # abort # stillbirth 
# infants surviving 
to 14 days 
% Survival 
to 14 days 
SPF Barrier 98 275 11 28 141 51 




Colony Single Twin Triplet Quad Quintuplet 
SPF Barrier 3 20 53 17 1 
SNPRC 10 78 114 28 2 





















































































































  Survival 
Colony Sex 2 years 5 years 8 years 
Barrier 
Male 100 90 68 
Female 100 80 68 
CLEA* 
Male 95 92 87 
Female 92 78 62 
SNPRC 
Male 78 60 38 
Female 80 50 22 
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Health outcome 
  
There were significant differences in the blood cell 
counts of barrier and SNPRC animals, including white 
blood cell (F (1,42) = 14.586, p<0.001), monocyte (F 
(1,42) = 14.808, p<0.001) and neutrophils (F (1,42) = 
17.208, p<0.001) (Table 4). Matched comparison of 
blood chemistry values also showed significant 
differences between colonies for albumin (F1,26) = 
8.032, p=0.009), globulin (F1,26) = 8.019, p = 0.009), 
and A/G ratio (F (1,26) =11.075, p=0.003). Regardless 
of which colony the animal was from, age was 
significantly correlated with lymphocyte count (r = -
0.311, p=0.04), alkaline (r= 0.551, p=0.002), globulin 
(r= 0.57, p=0.001), BUN (r= -0.434, p=0.17), A/G (r= -
0.516, p=0.003), and BC (r= -0.425, p=0.019). There 
were no significant changes in blood parameters for 
individuals over the 18 months of sampling regardless 
of location. There were also no significant differences 
in any measured urinary parameters between the 
locations.  
  
There were very few adult deaths during the tenure of 
the barrier colony. There were only 12 female deaths 
and 7 male deaths from the original founders and the 































these deaths there were only a few for which conclusive 
pathology and cause of death were determined. A male 
age 4.5 y died from congestive heart failure and 
epilepsy. A male 2 y old appears to have died due to 
complications associated with diabetes. A male juvenile 
age 6 months died from congenital pancreatic failure. 
Siblings age 3.5 y died unexpectedly, the male from 
congenital gastrointestinal defect and the female from 
anemia. A female 4.5 y died from postpartum com-
plications. A female’s death was associated with cardiac 
and renal failure at 4.3 y.  For several deaths in the 
colony we do not have conclusive pathology or cause of 
death, we present here anecdotal symptomology noted 
around time of death.  A male age 7.6 y was found with 
a rectal prolapse of unknown etiology immediately prior 
to death. A female age 9 y exhibited signs of dehydra-
tion following infant delivery shortly prior to her death.  
Her mate age 8.6 y was noted to have enlarged 
hardened kidneys during a physical prior to his death of 
unknown cause.  One infant male age 22 days was 
being supplemented with formula and may have 
aspirated during feeding.  For the other 11 deaths there 
were no reported clinical symptoms or signs prior to 
death.  There is no evidence from the pathology reports 
that any animals in the barrier died due to inflammatory 

































Test SPF Barrier SNPRC Normal Range UNIT 
WBC* 6.06 + 0.06 10.7 + 0.09 1.8 - 8.1 (Thous/MM3) 
BASO 0.08 + 0.02 0.13 + 0.03 0 - 0.1 (Thous/MM3) 
EOS 0.05 + 0.02 0.1 + 0.03 0 - 0.2 (Thous/MM3) 
MONO* 0.29 + 0.04 0.86 + 0.2 0 - 0.6 (Thous/MM3) 
LYMPHS 3.7 + 0.4 4.2 + 0.4 0.7 - 5.0 (Thous/MM3) 
NEUT* 2.6 + 0.3 5.4 + 0.7 1.5 - 8 (Thous/MM3) 
ALK 138.4 + 19.3 183.5 + 22.2 5 - 113 U/L 
ALT 13.2 + 3.9 15.9 + 4.6 0 - 62 U/L 
ALBUMIN* 4.6 + 0.09 4.2 + 0.11 2.9 - 5.2 g/dL 
PROTEIN 7.4 + 0.12 7.35 + 0.14 5.2 - 8.1 g/dL 
GLOBULIN* 2.77 + 0.08 3.15 + 0.1 2.1 - 3.2 g/dL 
BUN 27.97 + 1.46 25.1 + 1.7 12 - 31 mg/dL 
CREATININE 0.36 + 0.02 0.4 + 0.02 0.3 - 0.5 mg/dL 
GLUCOSE 166.9 + 12.2 152.5 + 14.04 92 - 244 mg/dL 
A/G RATIO* 1.68 + 0.06 1.37 + 0.07 1.1 - 2  
B/C RATIO 80.3 + 4.7 63.1 + 5.4 30 - 81.2  






















































































































Colony (n) Cluster 1 Cluster 2 Cluster 3 
Barrier (38) 16% 10% 74% 
Conventional (16) 62% 13% 25% 
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By contrast, in the comparative SNPRC population 
there were five deaths of animals under the age of one 
year for which the cause of death was determined to be 
necrotizing colitis, two that were noted as failure to 
thrive infants with extensive amyloidosis, two with 
Pseudomonas septicemia, and three with diarrhea 
associated with colitis. Between the ages of one year 
and two years four animals died due to necrotizing 
colitis, eight deaths were colitis associated, three deaths 
were associated with pneumonia, one death was due to 
cholangitis, two deaths were a result of trauma, and two 
were associated with amyloidosis. For animals aged 2-5 
y there was one death associated with necrotizing 
colitis, six due to colitis, one due to pneumonia, one due 
to cholangitis, five associated with amyloidosis, two 
individuals with lymphoma, three deaths due to 
nephritis, one animal died due to cardiomegaly, and one 
female died during delivery due to dystocia. For 
animals between the ages of 5 -8 y there were seven 
deaths associated with colitis, one death due to 
cholangitis, one death due to lymphoma, one associated 
with nephritis and one female death due to postpartum 
complications. For animals over the age of eight there 
were two deaths associated with colitis, two deaths due 
to amyloidosis, three deaths due to nephritis, and five 




The lack of gastrointestinal problems in the SPF barrier 
colony and the litany of gastrointestinal problems 
observed in the SNPRC animals might be linked to 
differences in the composition and function of microbial 
communities in their gastrointestinal tracts. Sequences 
of the 16S ribosomal RNA gene were used to charac-
terize microbial community composition for each of 38 
SPF marmosets and 16 SNPRC marmosets. A subset of 
19 microbial taxa were used in the comparison because 
these taxa occurred in at least one sample at a frequency 
of 5%. A hierarchical cluster analysis of the microbial 
communities based upon the frequencies of these taxa 
was performed (Figure 2). This analysis showed that the 
gastrointestinal microbiomes of barrier and SNPRC 
animals differed in terms of the kinds and abundances 
of various bacterial taxa (Figure 2B).  There were three 
major clusters that grouped together microbiomes with 
similar bacterial compositions. The frequencies of the 
clusters in the two colonies were significantly different 
(Table 5; χ2= 12.8, simulations=5,000, p-value< 0.002) 
[27].   
 
The frequencies of Bifidobacterium and Fusobacterium 
B (a group that is mischaracterized as Clostridium XIX) 
largely determined membership within a given cluster, 
and they were negatively correlated with each other 
(Figure 2). Thus, communities in Cluster 1, which was 
the predominant type in the SNPRC colony, had 
comparatively high frequencies of Fusobacterium B 
(>6%, median=27%) and low frequencies of 
Bifidobacterium (<8%, median=4%). In contrast, 
communities in Cluster 3, which was predominant in 
the barrier colony, had higher frequencies of 
Bifidobacterium (median=17%) and lower frequencies 
of Fusobacterium B (median=1%) with only a single 
exception, which had high frequencies of both. 
Communities of Cluster 2 had the highest frequencies of 
Bifidobacterium, >50% (median=70%) and the lowest 
frequencies of Fusobacterium B (median=0.0%). 
Animals with these communities were infrequent in 




One of the techniques in animal husbandry that has 
helped to reduce deaths due to infectious disease, and to 
increase the likelihood that deaths are due to age rather 
than other environmental factors, is the development of 
specific pathogen free colonies with implemented 
barrier conditions.  Rodent colonies for biomedical 
research began implementing procedures for deriving 
specific pathogen free lineages in the 1980’s and 
husbandry practices altered dramatically to include 
barrier protocols [25, 26, 28]. The implementation of 
barrier protocols has resulted in major changes to the 
reported maximum lifespan for many mouse lineages, 
for example 129/J mice were reported to have an 
increase in lifespan of 22% from 648 days in 1966 to 
791 days in 2009 [29].  While there may be a variety of 
causes for this increased lifespan, most researchers and 
colony managers agree that the implementation of 
HEPA filtered air systems, controlled diets, and sealed 
rack units have resulted in decreased infectious disease 
spread and decreased stress for the animals. The 
implementation of these husbandry practices was not 
just beneficial to animal welfare, health and aging, it 
has resulted in improved health for the caregivers, and 
increased quality and repeatability of research between 
research sites [25].  
 
Establishment of nonhuman primate SPF colonies have 
been largely driven by the needs of specific research 
agendas and not to support the development of aging 
studies. The most well-established SPF nonhuman 
primate is the rhesus macaque which has been cleared 
of tuberculosis, simian retrovirus (SRV), simian 
immunodeficiency virus (SIV), and Herpes B virus 
[30]. As opposed to our efforts, the main driving force 
for the establishment of these SPF rhesus macaque 
colonies has been to support SIV/AIDS research [30], 
as well as clearing the species of a pathogen that is 
potentially fatal to humans. A baboon colony that is 
SPF for five herpesviruses, four retroviruses, simian 
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virus 40, measles and monkey pox was established at 
the Oklahoma Health Science Center [31], primarily to 
support the use of baboons in transplantation studies 
requiring immunosuppression. The Barshop marmoset 
colony was the first new world monkey self-
propagating SPF colony to be developed. Marmosets 
were selected as a species in which to develop an SPF 
barrier colony for aging research because their lifespan, 
size and social characteristics make them ideal for 
biomedical research and specifically aging research. 
Marmosets do not pose a zoonotic risk for human 
caretakers and researchers since they are not carriers of 
the herpes B virus that macaques carry [32].  
 
The choice of pathogens to screen for and remove in the 
development of the marmoset SPF colony was 
complicated by our limited understanding of the 
relationship of viral infections to disease in this species. 
One of the viruses (CHV) has been proposed to be a 
possible cause of lymphomas, however others dispute 
this claim [33, 34]. The screen for viral, bacterial and 
parasitic pathogen presence revealed few animals that 
were free from all identified agents. Interestingly the 
SPF colony was able to be derived without the need for 
removing infants from the mother shortly after delivery 
and nursery rearing with other infants, or the more 
stringent cesarean derivation that has been implemented 
in a number of SPF colonies [30, 31, 35]. Adult 
marmosets were identified that were negative for both 
viruses and the identified bacterial and parasitic 
pathogens of interest.  With the exception of one male, 
all animals remained negative for the viruses, and few 
were found to be positive for Giardia during the years 
of follow-up. This is quite different from the viruses of 
interest in Old World monkey SPF colonies such as 
herpes B, which sporadically break through, appearing 
in previously sera-negative animals either due to latent 
tendencies or in utero transmission. Thus, the marmoset 
SPF colony could be derived without the use of infant 
isolation from the family group to maintain viral 
negative animals.  
 
Preventing bacterial and parasitic pathogens was not as 
easy, with Giardia being prevalent in the conventional 
colony and appearing sporadically in the SPF colony. 
While Giardia can be treated with Tinidazole, the rate 
of false positives in the assays and the inability to detect 
it during the latency period made it more difficult to 
remove from the SPF colony. However, Giardia was 
noted to occur at significantly lower rates and did not 
spread through the SPF colony. Animals in the SPF 
colony that had a positive Giardia result were tested 
regularly as follow-up and none had a repeat positive 
result, whereas animals in the SNPRC colony did 
repeatedly test positive and were treated with 
Tinidazole. Further, we did not have deaths in the SPF 
colony that were directly associated with 
gastrointestinal disease which has been associated with 
intestinal infections including Giardia [36].  
 
The Barshop marmoset colony quickly established as a 
self-propagating SPF breeding colony in which infants 
were successfully raised by their SPF parents. In fact, 
the production and success of the SPF colony was 
significantly better than the conventional colony. While 
rotational hand-rearing and investment by the marmoset 
staff in early infants did increase the rate of success for 
triplet litters, the overall success of the colony was 
better for all litter types. The elimination of specific 
pathogens and maintenance in strict barrier conditions 
increased infant survivorship and decreased juvenile 
and early adult deaths. Of particular importance for 
establishing aging research colonies, marmosets can be 
bred and continually housed socially under barrier 
conditions – something that is decidedly more difficult 
to accomplish with large-bodied Old World monkeys. 
 
There were differences in some blood chemistry values 
between the SPF and conventional colonies. Most of the 
blood and urinary values fell well within normal range 
for marmosets. The SPF colony did exhibit significantly 
decreased white blood cell, monocyte and neutrophil 
count when compared to the conventional colony.  
While typically within the normal range, the 
conventional colony had individuals with values at the 
top of the range. These results suggest that on average 
the marmosets in the SPF colony had lower antigen 
exposure rates than the conventional colony. 
 
The Barshop colony had significantly increased early 
and mid-adult age-specific survivorship when compared 
to most other marmoset colonies. The results were 
similar to those of the colony that reported the highest 
average median and maximum life span [37]. One 
interesting difference in the SPF barrier colony from 
both the SNPRC conventional colony and the CLEA 
colony is the lack of a sex difference in survivorship. 
Nishijima et al. (2012) report significantly lower age-
specific survival in marmoset females than in males, a 
finding that we have also reported previously for the 
SNPRC marmoset colony [38]. The reasons for this 
difference are unclear. 
 
The New England Primate Center previously reported 
causes of death within their marmoset colony between 
2004 and 2009 as primarily inflammatory bowel 
disease, conspecific injury, and infectious disease of the 
gut and kidney [21]. The primary causes of death for 
marmosets under the age of 6 at SNPRC between 2002 
and 2011 were irritable bowel disease and colitis [20]. 
These causes of death for animals under the age of 6 
were not seen in the Barshop SPF colony. Coincident 
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with these differences in causes of death is the striking 
difference in the gastrointestinal tract microbiomes of 
the SPF and SNPRC colonies. Whether these 
differences are due to the selection of founding animals 
with specific microbiomes, or to changes that occurred 
after the colony was established is unknown. The 
differences may also reflect differences in the environ-
mental conditions and/or the exclusion of specific 
organisms.  It would certainly be interesting to know 
whether the improved health in the barrier colony, and 
the lack of deaths due to intestinal diseases are related 
to the differences in microbial community composition.  
 
The plateau effect for adult longevity depicted by the 
barrier colony is presumably due to the decreased 
exposure to infectious agents and pathogens rather than 
genetic effects on longevity since the barrier colony was 
founded from the SNPRC conventional colony. All of 
the health and colony indicators suggest that 
maintenance in a barrier reduced early mortality, 
increased colony rate of growth, and supported 
significantly healthier marmosets. The ability to detect 
differences in lifespan and mortality rates in association 
with colony management and husbandry techniques 
may indeed be valuable for future aging research.  
 
A future question to address is the extent to which 
barrier procedures, such as autoclaved water, irradiated 
food, high air exchanges, and enhanced personal 
protective equipment contributes to these improved 
outcomes, as opposed to the simple fact of having a 
closed colony. We have previously reported that we 
have observed improvements in early-adult survivorship 
when the SNPRC colony was retained as closed (2001-
2006) and those improvements disappeared when the 
colony was opened to importation of new animals to 
support colony growth [21]. In addition, the CLEA 
colony has been closed to new animals for over three 
decades but does not report using barrier techniques 
for maintenance. It is possible that simply preventing 
the influx of pathogens from outside sources is enough 
to increase longevity and health-span in marmosets and 
that full barrier techniques are not necessary. How-
ever, almost all rodent models of aging and health-
span are maintained under barrier protocols, and the 
ability to translate results from rodent experimentation 
to primate models require barrier protocols to be 
designed and evaluated for primates.  While there is 
certainly room for further enhancement and testing of 
barrier techniques for use with marmosets, the Barshop 
SPF barrier colony firmly supports that marmosets can 
be bred and maintained in an environment ideal for 
aging research, and the health and longevity of these 




Marmosets offer a unique model for biomedical 
research and for aging studies in particular. The shorter 
lifespan, small size, and ease of care make them ideal as 
a nonhuman primate model. The ability to successfully 
create a specific pathogen free colony of breeding 
marmosets offers the opportunity to broaden their use 
by researchers to investigate causes of age related 




Specific pathogen free marmosets 
 
The SPF barrier marmoset colony was begun at the 
Barshop Institute for Longevity and Aging Studies, 
University of Texas Health Science Center at San 
Antonio in 2006. In order to populate this colony, 
animals from the Southwest National Primate Research 
Center were screened for several identified agents 
associated with pathogenic outcomes. Blood from 
animals of interest was screened for the presence of the 
viruses GB virus-A (GBV) and Callitrichine Herpes 
virus-3 (CHV) by the Lanford viral core at the Texas 
Biomedical Research Institute [39, 40].  Marmoset 
blood was obtained with EDTA anticoagulant. Plasma 
was removed after centrifugation. The cell pellet was 
suspended with PBS to 1 ml. DNA was purified from 
the 200 µl of the cell suspension using a Qiagen mini-
DNA column purification kit. DNA was eluted in a 
volume of 25 µl of water and the concentration was 
determined by using a Nanodrop ND-1000. TaqMan 
real time PCR amplification for CHV DNA was 
performed with 200 ng of cell DNA using an ABI 7500 
TaqMan machine with the ABI Fast Advance PCR 
solution. The TaqMan primers and probe were designed 
against the major internal repeat of CHV. The primers 
and probe were: forward primer 
(TGGGCCTAGTCTCCCCATAGA), reverse primer 
(GTGAGGGAGTCCATAAGGAAACTTT), and a 
Fam-Tamra labeled probe (CGCCTGTATGTCTTACT 
GGGACCCCTG). The RT-PCR assay for GBV-A 
RNA was a gel based assay. Multiple attempts to 
develop a quantitative TaqMan RT-PCR were not 
successful. The sequence of GBV-A was not available 
from multiple isolates. The target region selected for 
this assay was based on available sequences and was 
variable (Buhk). Sequence of the target region from 
animals within the SNPRC colony, confirmed the 
sequence variation confounding the ability to develop a 
probe for the detection of all isolates. The RT-PCR used 
for this project employed a single round of 40 cycles of 
amplification followed by detection of the product by 
agarose gel electrophoresis and ethidium bromide 
staining. RNA was purified from 50 µl of plasma using 
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RNA-Bee following the manufacturer’s protocol. The 
final RNA pellet was suspended in 50 µl of water and 
10 µl was amplified using the Invitrogen RT-PCR 
Superscript Kit for Long Templates. The primers 
detected a 400 nucleotide region in the 5’untranslated 
region (UTR) of marmoset GBV-A. The primers were: 
forward primer (AGGGTTCGTAGGTGGTAAATCCC) 
and  reverse  primer (TGCCACCAGGGGTCACCCGA 
AG).  
 
Fecal samples from candidate animals were evaluated 
for the presence of Giardia spp., Cryptosporidium spp., 
Clostridium perfringens, helminths, parasitic ova, 
enteropathic E. coli, Campylobacter spp., and 
Trichimonas spp. through IDEXX commercial 
veterinary screening services. In initial screenings of the 
SNPRC colony no marmoset tested positive for the 
presence of Campylobacter spp. or Trichimonas spp. 
and these assays were dropped from further 
assessments. Screening for all other pathogens was done 
prior to colony formation and then periodically after the 
formation of the SPF colony. The first SPF male-female 
pair of marmosets was moved to the barrier facility at 
the Barshop Institute July 2007. The initial formation of 
the colony consisted of a total of 12 founder animals, 
with animals entering between July 2007 and April 
2010. In order to assess the maintenance of the colony 
as specific pathogen free, viral screening occurred for 
all animals six months after entry to the barrier and 
sentry animals (one from each family group) were six 
years after formation of the colony. Fecal collections to 
assess the presence of Giardia, Cryptosporidium, and 
Clostridium perfringens were done annually following 




The first barrier rooms of the colony were two 10’x 29’ 
rooms within the animal care facility at the Barshop 
Institute located at the UT Health San Antonio Texas 
Research Park. Rooms were equipped with bioBubble 
units (Fort Collins CO, www.biobubble.com) consisting 
of two HEPA filtered airshower power units providing 
200-300 air changes per hour in the 10’ x 18’ animal 
vivarium space (Figure 3A). The front entry of the room 
contained clean PPE storage for entry into the screened 
vivarium. Each room maintained a positive air pressure 
to the outside hall. All items within the bioBubble and 
entering the bioBubble area were considered clean and 
rigorous SOP’s to ensure cleanliness were used. The 
vivarium housed six family units consisting of at most 
two adults, four independent offspring and two-three 
dependent offspring in marmoset breeding cages 
measuring (1.3 x 1.5 x 0.6m) made of stainless steel 
specifically designed for this colony (LGL) (Figure 3B). 
All items entering the barrier were sanitized prior to 
entry or autoclaved. Water bottles were autoclaved 
before use, and all water used in the room was 
autoclaved. The paper placed under the cage to capture 
waste was DACB neomycin coated cage liner 
(Shepherd Specialty Paper, Watertown, TN) to decrease 
the potential for aerosolized urinary product and 
contamination between cages. Personal protective 
equipment for the facility included standard shoe 
covers, hair bonnet, face mask and gloves as well as a 
disposable outer gown. Staff was required to enter the 
barrier rooms prior to work with any other animals or 
entry into other animal facilities. Clean scrubs were 
required to enter the barrier spaces, and if a staff 
member had already entered another animal room they 
were required to shower before entering the marmoset 
barrier. 
 
SPF marmosets in the barrier were fed a purified diet to 
prevent food borne pathogens from entering the colony. 
The Harlan Teklad purified marmoset diet (TD99468) 
used by SNPRC [41] was modified to be irradiated at 
the production factory and double bagged in 1kg 
portions. This purified diet was prepared under a hood 
using gelatin as the setting agent and autoclaved water. 
The food containers were sealed under the hood and 
transported to a refrigerator in the animal room. Due to 
the unusual nature of the facility food enrichment was 
restricted within the barrier. An irradiated primate 
enrichment mix consisting of nuts, seeds, and dried fruit 
from Harlan Teklad was given daily. In cases of ill 
animals, or animals that were deemed to need sup-
plements, items were chosen that could be purchased in 
sealed single use containers such as baby food or high 
calorie nutrition drinks, and unused portions were 
disposed of daily. 
 
In May 2013 the SPF marmoset colony was moved to a 
new Barrier space at the Barshop Institute (Figure 3C). 
This new barrier space was 2850 ft2 decommissioned 
and reconfigured BSL3 space in the animal vivarium. 
This new barrier facility consisted of a pass-through 
double door entry, a food preparation room, laboratory 
procedure room, four animal holding rooms (~180ft2 
each), a surgical suite, and 2 autoclave entry areas. The 
isolated air filtration system in this space was modified 
such that instead of HEPA filtration preventing 
contaminants from leaving the space the filtration 
prevented contaminants from entering the space.  The 
entire space once entering through the pass through 
double door entry was considered clean barrier space. 
The air exchange in this facility was also maintained at 
the higher rate of 200 changes per hour. Humidifiers 
(Humidifirst) were added to each animal holding room 
that use double filtered RO water to maintain room 
humidity between 35 and 40%. Barrier protocols were 
maintained similarly to the bioBubble space and all 
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other general maintenance and husbandry protocols 
were adopted from SNPRC’s marmoset colony [42]. 
The research adhered to ethical guidelines for 
primatological research as outlined by the American 
Society of Primatologists and the Institutional Animal 
Care and Use Committee at the University of Texas 
Health Science Center San Antonio and SNPRC.  
 
Health monitoring  
  
To compare the health outcomes for SPF marmosets 
maintained in a barrier to conventionally housed 
marmosets we evaluated blood CBC and blood 
chemistry of all animals in the barrier to age and sex 
matched animals maintained in the SNPRC marmoset 
breeding colony. All of the blood counts were done in 
the Tardif lab by a single technician, and the blood 






































Additionally, urine was collected for these age- and sex-
matched individuals and basic urinary values were 
assessed using a strip test to establish values of protein, 
glucose, ketone, specific gravity and presence of blood 
in the urine. Results from the two colonies were 
compared statistically using SPSS 23.0 repeated 
measures ANOVA.  
  
To examine longevity in the SPF colony, age at death 
for individuals in the barrier were compared to the 
SNPRC colony records for age of death during the same 
date frame. We compared survival in a population of 
247 barrier animals (115 females and 132 males) versus 
a population of 370 conventionally housed animals (173 
females and 197 males) over a 10-year period. The final 
date of comparison was August 2016 and animals were 
censored from the data if they were still alive at the end 
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primate facility, or if death was associated with an 
experimental protocol. For marmosets, the first two 
weeks of life present a high risk of neonatal death and 
are typically removed from longevity analyses, as we 
did here. Survivorship curves were estimated using 
Kaplan-Meier estimation, Cox proportional hazard 
model and Fisher’s exact test with males and females 
evaluated separately.  
 
Microbial community analysis 
  
To evaluate the microbial diversity of the marmoset 
gastrointestinal tract, 38 marmosets living in the barrier 
colony and 16 marmosets from the conventionally 
housed SNPRC colony were sampled between October, 
2011 and April, 2012. A fecal sample was taken from 
each marmoset by inserting a mini e-swab (Copan 
Diagnostics) into the rectum. E-swabs were stored in 
Amies transport medium and immediately frozen at -
80° C. Samples were mailed to the University of Idaho 
on dry ice and stored at     -80° C. Using methodology 
that is standard at the University of Idaho [43], DNA 
was extracted from the fecal samples, and the V1-V3 
region of the 16S ribosomal RNA gene (universal 16S 
rRNA primers 27F and 534R) was amplified and then 
sequenced by an Illumina MiSeq. Sequence reads were 
processed for quality and assigned to best taxonomic 
level by the IBEST Genomics Resources Core 
(http://www.ibest.uidaho.edu/cores/genomic-resources-
core/). The depth of coverage for each community was 
sufficient to detect taxa that constituted ≈0.01% of a 
community. Taxa that occurred at low frequency were 
removed from further consideration (ie: if a taxon had 
no single sample with a frequency greater than 5%).  
 
The R statistical package, vegan, was used to calculate 
alternative Gower distances among samples based upon 
taxon frequencies, and these distances were clustered by 
a hierarchical algorithm, hclust, using complete linkage. 
The number of clusters was determined by eye and 
confirmed using silhouette plots. The number of 
samples from barrier and conventional marmosets were 
enumerated for each cluster, and Fisher’s exact test 
using simulated p-values was used to test for random 
associations between cluster and colony type. A 
stepwise discriminant analysis was used to determine 
whether specific bacteria contribute to the placement of 
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